Semaglutide is a GLP-1 receptor agonist used in approved medicines for specific indications including type 2 diabetes and chronic weight management.

The Beligas Pharma listing specifies 5 mg but does not establish the dosage form, formulation, package quantity, or relationship to an approved semaglutide product.

Semaglutide therapy requires appropriate prescribing and monitoring. GORoids should verify the product’s labeling, storage requirements, manufacturer information, and regulatory status before publication.